Beta-Catenin and Epithelial Tumors: A Study Based on 374 Oropharyngeal Cancers

Figure 4

Kaplan-Meier curves ((a) overall survival and beta-catenin expression; (b) disease free survival and beta-catenin expression). Survival estimates have shown that OSCCS/OPSCCs overexpressing beta-catenin (cut-off >60%) are characterized by a worse prognosis, in terms of overall survival (𝑃<0.0153; survival median of 28 months in high expressing tumors versus 66 months in low expressing OSCCs/OPSCCs) (a) and disease-free survival, with a more evident tendency to relapse and metastasis (𝑃<0.0254; survival median of 20 months in high expressing tumors versus 30 months in low expressing OSCCs/OPSCCs) (b).

(a)

(b)